News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
New Liquid Biopsy Detects Cancer at Earlier Stages Than Currently Possible
Jim Daley | Jun 1, 2018
The test can pick up several types of cancer, including pancreatic and ovarian, years before symptoms appear.
New Ovarian Cancer Vaccine Shows Promise
Catherine Offord | Apr 12, 2018
A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
Hundreds of Inherited Gene Variants Contribute to Cancer
Abby Olena | Apr 5, 2018
In the largest study of its kind to date, researchers find more than 850 rare, heritable genetic alterations that can predispose humans to cancer.
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
Ilana Chefetz Confronts Ovarian Cancer
Jim Daley | Apr 1, 2018
The University of Minnesota researcher is on the front lines in the fight against the disease.
Molecule Found in Huntington’s Patients Kills Cancer Cells
Jim Daley | Feb 13, 2018
Researchers were able to slow tumor growth in a mouse model of human ovarian cancer.
Liquid Biopsy Test May Help Screen Eight Types of Cancer
Jim Daley | Jan 22, 2018
The new diagnostic works by identifying cancer-associated proteins and DNA in patient blood.
Henrietta Lacks’s Family Seeks Compensation
Kerry Grens | Feb 16, 2017
Family members of Lacks, the donor behind the widely used HeLa cell line, are planning to sue Johns Hopkins University.
Can Talc Cause Cancer?
Kerry Grens | Mar 2, 2016
A jury recently awarded $72 million in a talcum-powder–ovarian cancer case, but the data linking the hygiene product to disease risk are inconclusive.
Jenny Rood | Apr 21, 2015
Color Genomics announces a new, lower-cost BRCA mutation test, while Inserm and Quest Diagnostics reveal plans to pool patient data to investigate rare mutations.